Gsk (GSK) Receivables - Other (2009 - 2025)
Gsk (GSK) posted quarterly Receivables - Other of $1.5 billion for Q4 2025, up 38.7% year-over-year from $1.1 billion in Q4 2024, and up 38.7% quarter-over-quarter from $1.1 billion in Q4 2024.
Gsk (GSK) Receivables - Other (2009 - 2025) Analysis & Trends
Gsk's Receivables - Other history runs 17 years deep, the most recent figure standing at $1.5 billion for Q4 2025.
- In Q4 2025, Receivables - Other rose 38.7% year-over-year to $1.5 billion; the TTM figure through Dec 2025 stood at $1.5 billion (up 38.7% YoY), while the FY2025 annual figure was $1.5 billion, up 38.05% from the prior year.
- Receivables - Other for Q4 2025 stood at $1.5 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Receivables - Other was $15.2 billion in Q1 2022, with the low at $1.1 billion in Q4 2024.
- The 5-year median for Receivables - Other is $1.5 billion (2022), against an average of $3.7 billion.
- The sharpest annual moves came in 2022 and 2025: Receivables - Other dropped 15.74% in 2022, then jumped 38.7% in 2025.
- Gsk's Receivables - Other stood at $1.7 billion in 2021, then dropped by 15.74% to $1.4 billion in 2022, then fell by 9.81% to $1.3 billion in 2023, then retreated by 15.19% to $1.1 billion in 2024, then soared by 38.7% to $1.5 billion in 2025.
- Business Quant data shows GSK's Receivables - Other at $1.5 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.3 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.53 Bn |
| Dec 31, 2025 | 1.53 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Mar 31, 2022 | 15.20 Bn |
| Mar 31, 2022 | 15.20 Bn |
| Dec 31, 2021 | 1.71 Bn |
| Dec 31, 2021 | 1.71 Bn |
| Dec 31, 2020 | 1.34 Bn |
| Dec 31, 2020 | 1.34 Bn |
| Dec 31, 2019 | 1.77 Bn |
| Dec 31, 2019 | 1.77 Bn |
| Dec 31, 2018 | 1.15 Bn |
| Dec 31, 2018 | 1.15 Bn |
| Dec 31, 2017 | 1.29 Bn |
| Dec 31, 2017 | 1.29 Bn |